Geode Capital Management
BTTX

Geode Capital Management’s Better Therapeutics, Inc. Common Stock BTTX Stock Holding History

Geode Capital Management’s Portfolio BTTX Stock Details BTTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-168,821
Closed -$32.9K – 4664
2023
Q4 		$32.9K Buy
168,821
+61,943
+58% +$13.5K ﹤0.01% 4440
2023
Q3 		$41.2K Sell
106,878
-14,846
-12% -$10K ﹤0.01% 4462
2023
Q2 		$131K Buy
121,724
+64,615
+113% +$62.5K ﹤0.01% 4224
2023
Q1 		$41.6K Hold
57,109
– – ﹤0.01% 4559
2022
Q4 		$63K Sell
57,109
-135
-0.2% -$199 ﹤0.01% 4533
2022
Q3 		$100K Buy
57,244
+19,300
+51% +$35.2K ﹤0.01% 4580
2022
Q2 		$59K Buy
37,944
+3,097
+9% +$5.18K ﹤0.01% 4741
2022
Q1 		$68K Buy
+34,847
New +$120K ﹤0.01% 4750

Other funds holding BTTX

CIAS
Capital Investment Advisory Services Raleigh, North Carolina $1.62B AUM 27.01% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
APC
Aspire Private Capital Cornelius, North Carolina $484M AUM 17.28% 1-Year Est. Return

Geode Capital Management's BTTX Position: Q1 2024 in Review

Geode Capital Management sold out of Better Therapeutics, Inc. Common Stock (BTTX) in Q1 2024, closing a stake of 168,821 shares — an estimated $32.9K sold.

Geode Capital Management first reported a position in BTTX in Q1 2022 and held it in 8 quarters. The position peaked at $131K in Q2 2023. 3 funds tracked by Wall St. Rank hold BTTX as of Q1 2024.

  • Geode Capital Management reported no remaining Better Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Geode Capital Management sold 168,821 Better Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $32.9K.
  • Geode Capital Management first reported a position in Better Therapeutics, Inc. Common Stock in Q1 2022 and held it in 8 quarters.
  • Geode Capital Management's Better Therapeutics, Inc. Common Stock position peaked at $131K in Q2 2023.
  • 3 funds tracked by Wall St. Rank held Better Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Geode Capital Management's 13F filing for Q1 2024, filed 13 May 2024.